It is also possible that other Bcl-2 family members such as Bcl-XL or Bcl-W are upregulated in the adenomas, rendering ABT263 less effective, given that Bcl-2 is the critical ABT-263 target in vivo (42). Here, BCL2 is linked to adenoma.